Related Experiment Videos
Thrombolytic therapy for acute myocardial infarction in the 1990s
1Department of Medicine, Sinai Hospital of Baltimore, MD 21215.
Maryland Medical Journal (Baltimore, Md. : 1985)
|June 1, 1991
Insights
Intravenous thrombolytic agents effectively preserve heart function and reduce mortality in acute myocardial infarction. Future research in the 1990s will focus on adjunctive therapies to enhance thrombolysis treatment.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Intravenous thrombolytic agents proved effective in the 1980s for acute myocardial infarction.
- Established benefits include preserving left ventricular function and decreasing mortality.
Purpose of the Study:
- To outline the future direction of acute myocardial infarction treatment.
- Focus on adjunctive therapies to thrombolysis in the 1990s.
Main Methods:
- Literature review of 1980s myocardial infarction treatment outcomes.
- Projected research trends for the 1990s.
Main Results:
- Thrombolytic therapy is a cornerstone treatment for acute myocardial infarction.
- Adjunctive therapies are identified as the next frontier.
Conclusions:
- The 1980s established thrombolysis efficacy.
- The 1990s will prioritize optimizing treatment through adjunctive strategies.
Abstract:
The efficacy of intravenous thrombolytic agents in preserving left ventricular function and in decreasing mortality from an acute myocardial infarction was demonstrated in the 1980s. The 1990s will concentrate on adjunctive therapy to thrombolysis in the treatment of an acute myocardial infarction.